Abstract
Objectives This study had the goal of evaluating the role of treatment satisfaction among diabetic patients in the context of health-related quality of life (QoL) and medication adherence. Methods This study, which utilized a cross-sectional design, was conducted at the Primary Healthcare Unit in the Ministry of Health in Ramallah between Feb. and May 2019. Medication adherence was evaluated with the 4-item Morisky Green-Levine (MGL) questionnaire, treatment satisfaction using the Treatment Satisfaction Questionnaire for Medication version 1.4 (TSQM 1.4), and health-related quality of life with the European Quality of Life scale (EQ-5D-3L). Results Study participants consisted of 380 diabetic patients, of which 220 (57.9%) had high adherence to their medications and 160 (42.1%) had low adherence. Based on the classification of patient responses among the EQ-5D domains, pain/discomfort was the most influenced dimension, with 173 patients (36.1%) reporting problems, (36.1%). Also prominent were anxiety and depression (128 patients, 33.7%) and Mobility (115 patients, 30.3%). A significant relation was observed between QoL and treatment satisfaction (73.8 vs. 69.8; P = 0.016). Treatment satisfaction also had a significant association with the anxiety domain (39.4 vs. 28.7; P = 0.031). Conclusion Participants expressed moderate satisfaction with their treatments; more satisfied patients showed greater medication adherence and had better QoL. Anxiety has been shown to be associated with reduced medication adherence and lower QoL.
Highlights
The chronic progressive disease diabetes mellitus (DM) is associated with elevated blood glucose level caused by impaired insulin production, impaired insulin function, or both [1]
The duration of the first diabetes diagnosis for approximately 30% of patients was at least 10 years
Hyperlipidemia was a major complication of T2DM in (14.5%) of patients, while CVD affected (2.4%) of patients
Summary
The chronic progressive disease diabetes mellitus (DM) is associated with elevated blood glucose level (hyperglycemia) caused by impaired insulin production, impaired insulin function, or both [1]. The burden of diabetes is increasing due to the universal increase in the prevalence of obesity and unhealthy lifestyles [3]. The worldwide prevalence of diabetes was about 8% in 2011 and is predicted to rise to 10% by 2030, making DM a major cause of death globally [4]. The prevalence of DM in Palestine has increased significantly [5], leading to increased risk of complications, rates of morbidity and mortality, and spending on health care. The degree to which a patient implements lifestyle changes follows a diet or takes medication in keeping with the instructions of their health care provider is referred to as adherence [8]
Sign-in/Register to view highlights & summary Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
